Search research articles
Contact Us
Filters
Showing results (151-160 of 329) with videos related to
Page
of 33
Sort By:
Schizophrenia Bulletin
|
August 16, 2014
Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation
Paul Allen, Christopher A Chaddock, Alice Egerton, et al.
Molecular Psychiatry
|
May 13, 2022
The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study
Antoine Rogeau, Giovanna Nordio, Mattia Veronese, et al.
Archives of General Psychiatry
|
July 7, 2010
Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study
Paolo Fusar-Poli, Oliver D Howes, Paul Allen, et al.
Psychopharmacology
|
March 25, 2015
Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum
Matthijs G Bossong, Mitul A Mehta, Bart N M van Berckel, et al.
Schizophrenia Bulletin
|
February 1, 2012
Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals
Paul Allen, Judy Luigjes, Oliver D Howes, et al.
NPJ Schizophrenia
|
January 9, 2020
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research
Steven G Potkin, John M Kane, Christoph U Correll, et al.
Behavioural Brain Research
|
February 26, 2021
Effects of chronic exposure to haloperidol, olanzapine or lithium on SV2A and NLGN synaptic puncta in the rat frontal cortex
Els F Halff, Marie-Caroline Cotel, Sridhar Natesan, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 6, 2011
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability
Paul R A Stokes, Alice Egerton, Ben Watson, et al.
Genes, Brain, and Behavior
|
July 3, 2019
Disrupted-in-schizophrenia 1 functional polymorphisms and D<sub>2</sub> /D<sub>3</sub> receptor availability: A [<sup>11</sup> C]-(+)-PHNO imaging study
Tarik Dahoun, Matthew M Nour, Rick A Adams, et al.
Schizophrenia Research. Cognition
|
March 29, 2022
Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art
Philip D Harvey, Marta Bosia, Roberto Cavallaro, et al.
Page
of 33
Search research articles
Search
Showing results (151-160 of 329) with videos related to
Sort By:
Page
of 33
Schizophrenia Bulletin
|
August 16, 2014
Functional outcome in people at high risk for psychosis predicted by thalamic glutamate levels and prefronto-striatal activation
Paul Allen, Christopher A Chaddock, Alice Egerton, et al.
Molecular Psychiatry
|
May 13, 2022
The relationship between glutamate, dopamine, and cortical gray matter: A simultaneous PET-MR study
Antoine Rogeau, Giovanna Nordio, Mattia Veronese, et al.
Archives of General Psychiatry
|
July 7, 2010
Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study
Paolo Fusar-Poli, Oliver D Howes, Paul Allen, et al.
Psychopharmacology
|
March 25, 2015
Further human evidence for striatal dopamine release induced by administration of ∆9-tetrahydrocannabinol (THC): selectivity to limbic striatum
Matthijs G Bossong, Mitul A Mehta, Bart N M van Berckel, et al.
Schizophrenia Bulletin
|
February 1, 2012
Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals
Paul Allen, Judy Luigjes, Oliver D Howes, et al.
NPJ Schizophrenia
|
January 9, 2020
The neurobiology of treatment-resistant schizophrenia: paths to antipsychotic resistance and a roadmap for future research
Steven G Potkin, John M Kane, Christoph U Correll, et al.
Behavioural Brain Research
|
February 26, 2021
Effects of chronic exposure to haloperidol, olanzapine or lithium on SV2A and NLGN synaptic puncta in the rat frontal cortex
Els F Halff, Marie-Caroline Cotel, Sridhar Natesan, et al.
Journal of Psychopharmacology (Oxford, England)
|
September 6, 2011
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability
Paul R A Stokes, Alice Egerton, Ben Watson, et al.
Genes, Brain, and Behavior
|
July 3, 2019
Disrupted-in-schizophrenia 1 functional polymorphisms and D<sub>2</sub> /D<sub>3</sub> receptor availability: A [<sup>11</sup> C]-(+)-PHNO imaging study
Tarik Dahoun, Matthew M Nour, Rick A Adams, et al.
Schizophrenia Research. Cognition
|
March 29, 2022
Cognitive dysfunction in schizophrenia: An expert group paper on the current state of the art
Philip D Harvey, Marta Bosia, Roberto Cavallaro, et al.
Page
of 33